Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 63 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
621 16.0 months NSCLC 5 Biologic therapy
Chemotherapy
Radiation
Wisconsin Institute for Medical Research United States 1/2012
Treatment Details: Patients: This phase III study involved non–small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 275 patients with a median age of 63 y
 
622 16.0 months NSCLC 5 Biologic therapy
Chemotherapy
Radiation
Wisconsin Institute for Medical Research United States 2/2012
Treatment Details: Patients: This phase III study involved non–small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 275 patients with a median age of 63 years and
 
623 15.9 months BRAF V600-mutant advanced melanoma 5 Biologic therapy
Vanderbilt-Ingram Cancer Center United States 2/2012
Treatment Details: Patients: This phase 2 study involved 132 previously treated advanced metastatic melanoma patients who have a BRAF V600-mutation in the cancer cells. The median patient age was 51.5 years
 
624 15.9 months Non-squamous NSCLC 4 Chemotherapy
Penn State Milton S, Hershey Medical Center United States 4/2014
Treatment Details: Patients: This phase 2 study involved advanced non-squamous non–small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 55 patients with a median a
 
625 15.9 months GBM 4 Chemotherapy
Radiation
Dana Farber Cancer Institute United States 4/2015
Treatment Details: Patients: This phase 2 study involved newly diagnosed glioblastoma patients who were divided into two separate treatment groups. Group A consisted of 36 patients with a median age of 55 yea
 
626 15.9 months Stage IIIA and IIIB NSCLC 4 Chemotherapy
Surgery
Catalan Institute of Oncology, Hospital Germans Trais I Pujol Spain 10/2007
Treatment Details: Patients: This phase II trial involved 136 patients with stage IIIA and IIIB non-small cell lung cancer. The median age was 59.8 years, ranging from 31 to 77. Most (84.6%) patients were m
 
627 15.9 months hepatocellular carcinoma (advanced) 4 Chemotherapy
Hannover Medical School Germany 12/2005
Treatment Details: Patients: A total of 70 patients with advanced hepatocellular carcinoma were in enrolled in this phase II trial. Patients were divided into two groups of 35 each. Group A was comprised
 
628 15.9 months Stage IIIB or IV NSCLC 4 Biologic therapy
Chemotherapy
Toyohashi Municipal Hospital Japan 1/2009
Treatment Details: Patients: This phase 2 study involved forty-four patients with stage IIIB or IV non-small cell lung cancer. The majority (31) were men. The median age was 64, ranging from 34 to 75 years o
 
629 15.9 months metastatic breast cancer 5 Chemotherapy
Aristotle University of Thessaloniki Greece 7/2005
Treatment Details: Patients: This Phase I/II study involved 68 women with advanced breast cancer. The median age was 57 years. Forty patients had metastases Treatment: The treatment consisted of three che
 
630 15.8 months Hormone-refractory prostate cancer 5 Biologic therapy
Center for Cancer Research, National Cancer Institute United States 7/2001
Treatment Details: Patients: This Phase II study involved 63 patients with androgen-independent prostate cancer. Patients were divided into two groups: Group A (low dose arm) and Group B (high dose arm). For
 
Page 63 of 187  | Previous Page  | Next Page